- Home
- ARWR vs EAT Comparison
ARWR vs EAT Comparison
Compare ARWR & EAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- EAT
- Stock Information
- Founded
- ARWR 2003
- EAT 1975
- Country
- ARWR United States
- EAT United States
- Employees
- ARWR N/A
- EAT N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- EAT Restaurants
- Sector
- ARWR Health Care
- EAT Consumer Discretionary
- Exchange
- ARWR Nasdaq
- EAT Nasdaq
- Market Cap
- ARWR 5.9B
- EAT 7.0B
- IPO Year
- ARWR 1993
- EAT N/A
- Fundamental
- Price
- ARWR $40.96
- EAT $106.02
- Analyst Decision
- ARWR Strong Buy
- EAT Buy
- Analyst Count
- ARWR 8
- EAT 16
- Target Price
- ARWR $47.75
- EAT $161.06
- AVG Volume (30 Days)
- ARWR 1.7M
- EAT 1.7M
- Earning Date
- ARWR 11-25-2025
- EAT 10-29-2025
- Dividend Yield
- ARWR N/A
- EAT N/A
- EPS Growth
- ARWR N/A
- EAT 136.76
- EPS
- ARWR N/A
- EAT 9.64
- Revenue
- ARWR $572,976,000.00
- EAT $5,594,400,000.00
- Revenue This Year
- ARWR $21,287.22
- EAT $7.67
- Revenue Next Year
- ARWR N/A
- EAT $5.09
- P/E Ratio
- ARWR N/A
- EAT $10.97
- Revenue Growth
- ARWR 2816.20
- EAT 23.18
- 52 Week Low
- ARWR $9.57
- EAT $100.30
- 52 Week High
- ARWR $43.69
- EAT $192.22
- Technical
- Relative Strength Index (RSI)
- ARWR 60.87
- EAT 30.33
- Support Level
- ARWR $37.35
- EAT $100.30
- Resistance Level
- ARWR $42.00
- EAT $107.44
- Average True Range (ATR)
- ARWR 2.18
- EAT 4.84
- MACD
- ARWR -0.28
- EAT -0.64
- Stochastic Oscillator
- ARWR 61.35
- EAT 19.17
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About EAT Brinker International Inc.
Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.